Skip to main content

Effect of Intravenous Fentanyl on Ticagrelor Absorption and Platelet Inhibition Among Patients Undergoing Percutaneous Coronary Intervention: The PACIFY Randomized Clinical Trial (Platelet Aggregation With Ticagrelor Inhibition and Fentanyl).

Publication ,  Journal Article
McEvoy, JW; Ibrahim, K; Kickler, TS; Clarke, WA; Hasan, RK; Czarny, MJ; Keramati, AR; Goli, RR; Gratton, TP; Brinker, JA; Chacko, M; Trost, JC ...
Published in: Circulation
January 16, 2018

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Circulation

DOI

EISSN

1524-4539

Publication Date

January 16, 2018

Volume

137

Issue

3

Start / End Page

307 / 309

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Time Factors
  • Ticagrelor
  • Risk Assessment
  • Receptors, Purinergic P2Y12
  • Purinergic P2Y Receptor Antagonists
  • Platelet Function Tests
  • Platelet Aggregation Inhibitors
  • Platelet Aggregation
  • Percutaneous Coronary Intervention
 

Citation

APA
Chicago
ICMJE
MLA
NLM
McEvoy, J. W., Ibrahim, K., Kickler, T. S., Clarke, W. A., Hasan, R. K., Czarny, M. J., … Schulman, S. P. (2018). Effect of Intravenous Fentanyl on Ticagrelor Absorption and Platelet Inhibition Among Patients Undergoing Percutaneous Coronary Intervention: The PACIFY Randomized Clinical Trial (Platelet Aggregation With Ticagrelor Inhibition and Fentanyl). Circulation, 137(3), 307–309. https://doi.org/10.1161/CIRCULATIONAHA.117.031678
McEvoy, John W., Khalil Ibrahim, Thomas S. Kickler, William A. Clarke, Rani K. Hasan, Matthew J. Czarny, Ali R. Keramati, et al. “Effect of Intravenous Fentanyl on Ticagrelor Absorption and Platelet Inhibition Among Patients Undergoing Percutaneous Coronary Intervention: The PACIFY Randomized Clinical Trial (Platelet Aggregation With Ticagrelor Inhibition and Fentanyl).Circulation 137, no. 3 (January 16, 2018): 307–9. https://doi.org/10.1161/CIRCULATIONAHA.117.031678.
McEvoy JW, Ibrahim K, Kickler TS, Clarke WA, Hasan RK, Czarny MJ, Keramati AR, Goli RR, Gratton TP, Brinker JA, Chacko M, Hwang C-W, Johnston PV, Miller JM, Trost JC, Herzog WR, Blumenthal RS, Thiemann DR, Resar JR, Schulman SP. Effect of Intravenous Fentanyl on Ticagrelor Absorption and Platelet Inhibition Among Patients Undergoing Percutaneous Coronary Intervention: The PACIFY Randomized Clinical Trial (Platelet Aggregation With Ticagrelor Inhibition and Fentanyl). Circulation. 2018 Jan 16;137(3):307–309.

Published In

Circulation

DOI

EISSN

1524-4539

Publication Date

January 16, 2018

Volume

137

Issue

3

Start / End Page

307 / 309

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Time Factors
  • Ticagrelor
  • Risk Assessment
  • Receptors, Purinergic P2Y12
  • Purinergic P2Y Receptor Antagonists
  • Platelet Function Tests
  • Platelet Aggregation Inhibitors
  • Platelet Aggregation
  • Percutaneous Coronary Intervention